Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Spinal Muscular Atrophy (SMA) is a rare neurogenerative disease that is largely invisible to society. A new campaign exposes its harsh reality as calls for early screening programs that can slow the disease’s progression circulate around Europe.
Biopharmaceutical company Biogen and patient association FundAME are behind the campaign, titled “Invisibles” and created by ad agency VMLY&R Health Spain. The effort raises awareness and calls for support for those living with SMA, which affects approximately one in 6,000–10,000 births in Europe.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in